Advertisement

DiGeorge Syndrome/Velocardiofacial Syndrome: The Chromosome 22q11.2 Deletion Syndrome

  • Kathleen E. Sullivan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 601)

Abstract

Chromosome 22q11.2 deletion (CH22qD) syndrome is also known as DiGeorge syndrome or velocardiofacial syndrome. This deletion syndrome is extremely common with nearly one in 4000 children being affected. Recent advances and a holistic approach to patients have improved the care and well-being of these patients. This review will summarize advances in understanding the health needs and immune system of patients with CH22qD syndrome. Patients will most often need interventions directed at maximizing function for many organ systems but can ultimately have a high level of functioning.

Keywords

Autistic Spectrum Disorder Chromosome 22q11 Juvenile Rheumatoid Arthritis Branchial Arch Deletion Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antshel, K.M., Fremont, W., Roizen, N.J., Shprintzen, R., Higgins, A.M., Dhamoon, A. and Kates, W.R. (2006) ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J. Am. Acad. Child Adolesc. Psychiatry 45, 596–603.CrossRefPubMedGoogle Scholar
  2. Bale, P.M. and Sotelo-Avila, C. (1993) Maldescent of the thymus: 34 necropsy and 10 surgical cases, including 7 thymuses medial to the mandible. Pediatr. Pathol. 13, 181–190.CrossRefPubMedGoogle Scholar
  3. Barnea-Goraly, N., Eliez, S., Menon, V., Bammer, R. and Reiss, A.L. (2005) Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome. Brain Res. Cogn. Brain Res. 25, 735–740.CrossRefPubMedGoogle Scholar
  4. Bastian, J., Law, S., Vogler, L., Lawton, A., Herrod, H., Anderson, S., Horowitz, S. and Hong, R. (1989) Prediction of persistent immunodeficiency in the DiGeorge anomaly. J. Pediatr. 115, 391–396.CrossRefPubMedGoogle Scholar
  5. Becker, D.B., Pilgram, T., Marty-Grames, L., Govier, D.P., Marsh, J.L. and Kane, A.A. (2004) Accuracy in identification of patients with 22q11.2 deletion by likely care providers using facial photographs. Plast. Reconstr. Surg.114, 1367–1372.CrossRefPubMedGoogle Scholar
  6. Bish, J.P., Pendyal, A., Ding, L., Ferrante, H., Nguyen, V., McDonald-McGinn, D., Zackai, E. and Simon, T.J. (2006) Specific cerebellar reductions in children with chromosome 22q11.2 deletion syndrome. Neurosci. Lett. 399, 245–248.CrossRefPubMedGoogle Scholar
  7. Botto, L.D., May, K., Fernhoff, P.M., Correa, A., Coleman, K., Rasmussen, S.A., Merritt, R.K., O’Leary, L.A., Wong, L.Y., Elixson, E.M., Mahle, W.T. and Campbell, R.M. (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101–107.CrossRefPubMedGoogle Scholar
  8. Campbell, L.E., Daly, E., Toal, F., Stevens, A., Azuma, R., Catani, M., Ng, V., van Amelsvoort, T., Chitnis, X., Cutter, W., Murphy, D.G. and Murphy, K.C. (2006) Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 129, 1218–1228.CrossRefPubMedGoogle Scholar
  9. Chen, Y.F., Kou, P.L., Tsai, S.J., Chen, K.F., Chan, H.H., Chen, C.M. and Sun, H.S. (2006) Computational analysis and refinement of sequence structure on chromosome 22q11.2 region: application to the development of quantitative real-time PCR assay for clinical diagnosis. Genomics 87, 290–297.CrossRefPubMedGoogle Scholar
  10. Chinen, J., Rosenblatt, H.M., Smith, E.O., Shearer, W.T. and Noroski, L.M. (2003) Long-term assessment of T cell populations in DiGeorge syndrome. J. Allergy Clin. Immunol. 111, 573–579.CrossRefPubMedGoogle Scholar
  11. Cipollone, D., Amati, F., Carsetti, R., Placidi, S., Biancolella, M., D’Amati, G., Novelli, G., Siracusa, G. and Marino, B. (2006) A multiple retinoic acid antagonist induces conotruncal anomalies, including transposition of the great arteries, in mice. Cardiovasc. Pathol. 15, 194–202.CrossRefPubMedGoogle Scholar
  12. Coberly, S., Lammer, E. and Alashari, M. (1996) Retinoic acid embryopathy: case report and review of literature. Pediatr. Pathol. Lab. Med. 16, 823–836.CrossRefPubMedGoogle Scholar
  13. Davies, K., Stiehm, E.R., Woo, P. and Murray, K.J. (2001) Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J. Rheumatol. 28, 2326–2334.PubMedGoogle Scholar
  14. DePiero, A.D., Lourie, E.M., Berman, B.W., Robin, N.H., Zinn, A.B. and Hostoffer, R.W. (1997) Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome. J. Pediatr. 131, 484–486.CrossRefPubMedGoogle Scholar
  15. Digilio, M.C., Marino, B., Formigari, R. and Giannotti, A. (1995) Maternal diabetes causing DiGeorge anomaly and renal agenesis Am. J. Med. Genet. 55, 513–514.CrossRefGoogle Scholar
  16. Digilio, M.C., Pacifico, C., Tieri, L., Marino, B., Giannotti, A. and Dallapiccola, B. (1999) Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br. J. Audiol. 33, 329–333.CrossRefPubMedGoogle Scholar
  17. Dunham, I., Shimizu, N., Roe, B.A., Chissoe, S., Hunt, A.R., Collins, J.E., Bruskiewich, R., Beare, D.M., Clamp, M., Smink, L.J., Ainscough, R., Almeida, J.P., Babbage, A., Bagguley, C., Bailey, J., Barlow, K., Bates, K.N., Beasley, O., Bird, C.P., Blakey, S., Bridgeman, A.M., Buck, D., Burgess, J., Burrill, W.D., O’Brien, K.P., et al. (1999) The DNA sequence of human chromosome 22. Nature 402, 489–495.CrossRefPubMedGoogle Scholar
  18. Fernandez, L., Lapunzina, P., Arjona, D., Lopez Pajares, I., Garcia-Guereta, L., Elorza, D., Burgueros, M., De Torres, M.L., Mori, M.A., Palomares, M., Garcia-Alix, A. and Delicado, A. (2005) Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin. Genet. 68, 373–378.CrossRefPubMedGoogle Scholar
  19. Finocchi, A., Di Cesare, S., Romiti, M.L., Capponi, C., Rossi, P., Carsetti, R. and Cancrini, C. (2006) Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr. Allergy Immunol. 17, 382–388.CrossRefPubMedGoogle Scholar
  20. Frohn-Mulder, I.M., Wesby Swaay, E., Bouwhuis, C., Van Hemel, J.O., Gerritsma, E., Niermeyer, M.F. and Hess, J. (1999) Chromosome 22q11 deletions in patients with selected outflow tract malformations. Genet. Couns. 10, 35–41.PubMedGoogle Scholar
  21. Gennery, A.R., Barge, D., O’Sullivan, J.J., Flood, T.J., Abinun, M. and Cant, A.J. (2002) Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch. Dis.Chil. 86, 422–425.CrossRefGoogle Scholar
  22. Gerdes, M., Solot, C., Wang, P.P., McDonald-McGinn, D.M. and Zackai, E.H. (2001) Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet. Med. 3, 40–44.CrossRefPubMedGoogle Scholar
  23. Gerdes, M., Solot, C., Wang, P.P., Moss, E., LaRossa, D., Randall, P., Goldmuntz, E., Clark, B.J., 3rd, Driscoll, D.A., Jawad, A., Emanuel, B.S., McDonald-McGinn, D.M., Batshaw, M.L. and Zackai, E.H. (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am. J. Med. Genet. 85, 127–133.CrossRefPubMedGoogle Scholar
  24. Golding-Kushner, K.J., Weller, G. and Shprintzen, R.J. (1985) Velo-cardio-facial syndrome: language and psychological profiles. J. Craniofac. Genet. Dev. Biol. 5, 259–266.PubMedGoogle Scholar
  25. Jawad, A.F., McDonald-McGinn, D.M., Zackai, E. and Sullivan, K.E. (2001) Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J. Pediatr. 139, 715–723.CrossRefPubMedGoogle Scholar
  26. Jiang, L., Duan, C., Chen, B., Hou, Z., Chen, Z., Li, Y., Huan, Y. and Wu, K.K. (2005) Association of 22q11 deletion with isolated congenital heart disease in three Chinese ethnic groups. Int. J. Cardiol. 105, 216–223.CrossRefPubMedGoogle Scholar
  27. Junker, A.K. and Driscoll, D.A. (1995) Humoral immunity in DiGeorge syndrome. J. Pediatr. 127, 231–237.CrossRefPubMedGoogle Scholar
  28. Kanaya, Y., Ohga, S., Ikeda, K., Furuno, K., Ohno, T., Takada, H., Kinukawa, N. and Hara, T. (2006) Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome. Clin. Exp. Immunol. 144, 85–93.CrossRefPubMedGoogle Scholar
  29. Kornfeld, S.J., Zeffren, B., Christodoulou, C.S., Day, N.K., Cawkwell, G. and Good, R.A. (2000) DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization. J. Allergy Clin. Immunol. 105, 983–987.CrossRefPubMedGoogle Scholar
  30. Lajiness-O’Neill, R., Beaulieu, I., Asamoah, A., Titus, J.B., Bawle, E., Ahmad, S., Kirk, J.W. and Pollack, R. (2006) The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology. Arch. Clin. Neuropsychol. 21, 175–184.CrossRefPubMedGoogle Scholar
  31. Lawrence, S., McDonald-McGinn, D.M., Zackai, E. and Sullivan, K.E. (2003). Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J. Pediatr 143, 277–278.CrossRefPubMedGoogle Scholar
  32. Levy, A., Michel, G., Lemerrer, M. and Philip, N. (1997) Idiopathic thrombocytopenic purpura in two mothers of children with DiGeorge sequence: a new component manifestation of deletion 22q11? Am. J. Med. Genet. 69, 356–359.CrossRefPubMedGoogle Scholar
  33. Lindsay, E.A., Botta, A., Jurecic, V., Carattini-Rivera, S., Cheah, Y.C., Rosenblatt, H.M., Bradley, A. and Baldini, A. (1999) Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401, 379–383.PubMedGoogle Scholar
  34. Losken, A., Williams, J.K., Burstein, F.D., Malick, D. and Riski, J.E. (2003) An outcome evaluation of sphincter pharyngoplasty for the management of velopharyngeal insufficiency. Plast. Reconstr. Surg. 112, 1755–1761.CrossRefPubMedGoogle Scholar
  35. Losken, A., Williams, J.K., Burstein, F.D., Malick, D.N. and Riski, J.E. (2006) Surgical correction of velopharyngeal insufficiency in children with velocardiofacial syndrome. Plast. Reconstr. Surg. 117, 1493–1498.CrossRefPubMedGoogle Scholar
  36. Mahadevan, N.R., Horton, A.C. and Gibson-Brown, J.J. (2004) Developmental expression of the amphioxus Tbx1/ 10 gene illuminates the evolution of vertebrate branchial arches and sclerotome. Dev. Genes Evol. 214, 559–566.CrossRefPubMedGoogle Scholar
  37. Markert, M.L., Boeck, A., Hale, L.P., Kloster, A.L., McLaughlin, T.M., Batchvarova, M.N., Douek, D.C., Koup, R.A., Kostyu, D.D., Ward, F.E., Rice, H.E., Mahaffey, S.M., Schiff, S.E., Buckley, R.H. and Haynes, B.F. (1999) Transplantation of thymus tissue in complete DiGeorge syndrome. N. Engl. J. Med. 341, 1180–1189.CrossRefPubMedGoogle Scholar
  38. Markert, M.L., Sarzotti, M., Ozaki, D.A., Sempowski, G.D., Rhein, M.E., Hale, L.P., Le Deist, F., Alexieff, M.J., Li, J., Hauser, E.R., Haynes, B.F., Rice, H.E., Skinner, M.A., Mahaffey, S.M., Jaggers, J., Stein, L.D. and Mill, M.R. (2003) Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 102, 1121–1130.CrossRefPubMedGoogle Scholar
  39. Markert, M.L., Watson, T., McLaughlin, T., McGuire, C.A., Ward, F.E., Kostyu, D., Hale, L.P., Buckley, R.H., Schiff, S.E., Bleesing, J.J.H., Broome, C.B., Ungarleider, R.M., Mahaffey, S., Oldman, K.T. and Haynes, B. (1995) Development of T cell function after post-natal thymic transplanation for DiGeorge syndrome. Am. J. Hum. Genet. 57, A14.Google Scholar
  40. McDonald-McGinn, D.M., Kirschner, R., Goldmuntz, E., Sullivan, K., Eicher, P., Gerdes, M., Moss, E., Solot, C., Wang, P., Jacobs, I., Handler, S., Knightly, C., Heher, K., Wilson, M., Ming, J.E., Grace, K., Driscoll, D., Pasquariello, P., Randall, P., Larossa, D., Emanuel, B.S. and Zackai, E.H. (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet. Couns. 10, 11–24.PubMedGoogle Scholar
  41. Moss, E.M., Batshaw, M.L., Solot, C.B., Gerdes, M., McDonald-McGinn, D.M., Driscoll, D.A., Emanuel, B.S., Zackai, E.H. and Wang, P.P. (1999) Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern. J. Pediatr. 134, 193–198.CrossRefPubMedGoogle Scholar
  42. Motzkin, B., Marion, R., Goldberg, R., Shprintzen, R. and Saenger, P. (1993) Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J. Pediatr. 123, 406–410.CrossRefPubMedGoogle Scholar
  43. Munoz, S., Garay, F., Flores, I., Heusser, F., Talesnik, E., Aracena, M., Mellado, C., Mendez, C., Arnaiz, P. and Repetto, G. (2001) Heterogeneidad de la presentacion clinica del sindrome de microdelecion del cromosoma 22, region q11. Revista Medica de Chile 129, 515–521.PubMedGoogle Scholar
  44. Niklasson, L., Rasmussen, P., Oskarsdottir, S. and Gillberg, C. (2005) Attention deficits in children with 22q.11 deletion syndrome. Dev. Med. Child. Neurol. 47, 803–807.CrossRefPubMedGoogle Scholar
  45. Novak, R.W. and Robinson, H.B. (1994) Coincident DiGeorge anomaly and renal agenesis and its relation to maternal diabetes Am. J. Med. Genet. 50, 311–312.CrossRefGoogle Scholar
  46. Parissis, D. and Milonas, I. (2005) Chromosome 22q11.2 deletion syndrome: an underestimated cause of neuropsychiatric impairment in adolescence. J. Neurol. 252, 989–990.CrossRefPubMedGoogle Scholar
  47. Piliero, L.M., Sanford, A.N., McDonald-McGinn, D.M., Zackai, E.H. and Sullivan, K.E. (2004) T cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 103, 1020–1025.CrossRefPubMedGoogle Scholar
  48. Pinchas-Hamiel, O., Engelberg, S., Mandel, M. and Passwell, J.H. (1994) Immune hemolytic anemia, thrombocytopenia and liver disease in a patient with DiGeorge syndrome. Isr. J. Med. Sci. 30, 530–532.PubMedGoogle Scholar
  49. Rasmussen, S.A., Williams, C.A., Ayoub, E.M., Sleasman, J.W., Gray, B.A., Bent-Williams, A., Stalker, H.J. and Zori, R.T. (1996) Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication. Am. J. Med. Genet. 64, 546–550.CrossRefPubMedGoogle Scholar
  50. Roberts, C., Ivins, S.M., James, C.T. and Scambler, P.J. (2005) Retinoic acid down-regulates Tbx1 expression in vivo and in vitro. Dev. Dyn. 232, 928–938.CrossRefPubMedGoogle Scholar
  51. Rommel, N., Vantrappen, G., Swillen, A., Devriendt, K., Feenstra, L. and Fryns, J.P. (1999) Retrospective analysis of feeding and speech disorders in 50 patients with velo-cardio-facial syndrome. Genet. Couns. 10, 71–78.PubMedGoogle Scholar
  52. Ryan, A.K., Goodship, J.A., Wilson, D.I., Philip, N., Levy, A., Seidel, H., Schuffenhauer, S., Oechsler, H., Belohradsky, B., Prieur, M., Aurias, A., Raymond, F.L., Clayton-Smith, J., Hatchwell, E., McKeown, C., Beemer, F.A., Dallapiccola, B., Novelli, G., Hurst, J.A., Ignatius, J., Green, A.J., Winter, R.M., Brueton, L., Brondum-Nielson, K., Stewart, F., Van Essen, T., Patton, M., Paterson, J. and Scambler, P.J. (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 34, 798–804.CrossRefPubMedGoogle Scholar
  53. Sediva, A., Bartunkova, J., Zachova, R., Polouckova, A., Hrusak, O., Janda, A., Kocarek, E., Novotna, D., Novotna, K. and Klein, T. (2005) Early development of immunity in diGeorge syndrome. Med. Sci. Monit. 11, CR182–CR187.PubMedGoogle Scholar
  54. Shaikh, T.H., Kurahashi, H., Saitta, S.C., O’Hare, A.M., Hu, P., Roe, B.A., Driscoll, D.A., McDonald-McGinn, D.M., Zackai, E.H., Budarf, M.L. and Emanuel, B.S. (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet. 9, 489–501.CrossRefPubMedGoogle Scholar
  55. Shprintzen, R.J., Goldberg, R., Golding-Kushner, K.J. and Marion, R.W. (1992) Late-onset psychosis in the velo-cardio-facial syndrome. Am. J. Med. Genet. 42, 141–142.CrossRefPubMedGoogle Scholar
  56. Simon, T., Bearden, C., Mc-Ginn, D. and Zackai, E. (2005a) Visuospatial and numerical cognitive deficits in children with chromosome 22q11.2 deletion syndrome. Cortex 41, 145–155.CrossRefPubMedGoogle Scholar
  57. Simon, T.J., Ding, L., Bish, J.P., McDonald-McGinn, D.M., Zackai, E.H. and Gee, J. (2005b) Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 25, 169–180.CrossRefPubMedGoogle Scholar
  58. Smith, C.A., Driscoll, D.A., Emanuel, B.S., McDonald-McGinn, D.M., Zackai, E.H. and Sullivan, K.E. (1998) Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Diagn. Lab. Immunol. 5, 415–417.PubMedGoogle Scholar
  59. Solot, C.B., Gerdes, M., Kirschner, R.E., McDonald-McGinn, D.M., Moss, E., Woodin, M., Aleman, D., Zackai, E.H. and Wang, P.P. (2001) Communication issues in 22q11.2 deletion syndrome: children at risk.. Genet. Med. 3, 67–71.CrossRefPubMedGoogle Scholar
  60. Solot, C.B., Knightly, C., Handler, S.D., Gerdes, M., McDonald-McGinn, D.M., Moss, E., Wang, P., Cohen, M., Randall, P., Larossa, D. and Driscoll, D.A. (2000) Communication disorders in the 22Q11.2 microdeletion syndrome. J. Commun. Disord. 33, 187–203.CrossRefPubMedGoogle Scholar
  61. Stalmans, I., Lambrechts, D., De Smet, F., Jansen, S., Wang, J., Maity, S., Kneer, P., von der Ohe, M., Swillen, A., Maes, C., Gewillig, M., Molin, D.G., Hellings, P., Boetel, T., Haardt, M., Compernolle, V., Dewerchin, M., Plaisance, S., Vlietinck, R., Emanuel, B., Gittenberger-de Groot, A.C., Scambler, P., Morrow, B., Driscol, D.A., Moons, L., Esguerra, C.V., Carmeliet, G., Behn-Krappa, A., Devriendt, K., Collen, D., Conway, S.J. and Carmeliet, P. (2003) VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat. Med. 9, 173–182.Google Scholar
  62. Sullivan, K.E., McDonald-McGinn, D., Driscoll, D., Emanuel, B.S., Zackai, E.H. and Jawad, A.F. (1999) Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Lab. Diagn. Immunol. 6, 906–911.Google Scholar
  63. Sullivan, K.E., McDonald-McGinn, D. and Zackai, E.H. (2002) CD4(+) CD25(+) T cell production in healthy humans and in patients with thymic hypoplasia. Clin. Lab. Diagn. Immunol. 9, 1129–1131.Google Scholar
  64. Swillen, A., Devriendt, K., Legius, E., Eyskens, B., Dumoulin, M., Gewillig, M. and Fryns, J.P. (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J. Med. Genet. 34, 453–458.CrossRefPubMedGoogle Scholar
  65. Swillen, A., Devriendt, K., Legius, E., Prinzie, P., Vogels, A., Ghesquiere, P. and Fryns, J.P. (1999) The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genetic. Couns. 10, 79–88.Google Scholar
  66. Theodoropoulos, D.S. (2003) Immune deficiency in CHARGE association. Clin. Med. Res. 1, 43–48.CrossRefPubMedGoogle Scholar
  67. Van Esch, H., Groenen, P., Fryns, J.P., Van de Ven, W. and Devriendt, K. (1999) The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome. Genet. Couns. 10, 59–65.PubMedGoogle Scholar
  68. Vantrappen, G., Devriendt, K., Swillen, A., Rommel, N., Vogels, A., Eyskens, B., Gewillig, M., Feenstra, L. and Fryns, J.P. (1999) Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet. Couns. 10, 3–9.Google Scholar
  69. Vorstman, J.A., Jalali, G.R., Rappaport, E.F., Hacker, A.M., Scott, C. and Emanuel, B.S. (2006) MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum. Mutat. 27, 814–821.CrossRefPubMedGoogle Scholar
  70. Wang, P.P., Woodin, M.F., Kreps-Falk, R. and Moss, E.M. (2000) Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev. Med. Child. Neurol. 42, 422–427.CrossRefPubMedGoogle Scholar
  71. Wilson, D.I., Burn, J., Scambler, P. and Goodship, J. (1993) DiGeorge syndrome: part of CATCH 22. J. Med. Genet. 30, 852–856.CrossRefPubMedGoogle Scholar
  72. Xu, H., Cerrato, F. and Baldini, A. (2005) Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development 132, 4387–4395.CrossRefPubMedGoogle Scholar
  73. Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Minoshima, S., Ichida, F., Joo, K., Kimura, M., Imamura, S., Kamatani, N., Momma, K., Takao, A., Nakazawa, M., Shimizu, N. and Matsuoka, R. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366–1373.CrossRefPubMedGoogle Scholar
  74. Yan, W., Jacobsen, L.K., Krasnewich, D.M., Guan, X.Y., Lenane, M.C., Paul, S.P., Dalwadi, H.N., Zhang, H., Long, R.T., Kumra, S., Martin, B.M., Scambler, P.J., Trent, J.M., Sidransky, E., Ginns, E.I. and Rapoport, J.L. (1998) Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired”. Am. J. Med. Genet. 81, 41–43.CrossRefPubMedGoogle Scholar
  75. Zhang, Z., Cerrato, F., Xu, H., Vitelli, F., Morishima, M., Vincentz, J., Furuta, Y., Ma, L., Martin, J.F., Baldini, A. and Lindsay, E. (2005) Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 132, 5307–5315.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Department of PediatricsDivision of Allergy & Immunology Children’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations